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The oxidation of intracellular myoglobin by 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid was studied 
in suspensions of isolated adult rat heart cells. Myoglobin was converted to a species identified as ferrylMb 
by its reaction with NasS to form ferrous sulfmyoglobin. This process was time-dependent and 
concentration-dependent in a manner consistent with direct accessibility of the exogenous peroxide to the 
cytosolic protein. The results indicate that myoglobin oxidation may be an early sign of oxidative injury 
and may limit myocardial function by elimination of this short-term 02 reserve. 
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1. INTRODUCTION 
15-Hydroperoxy-5,8,11,13-eicosatetraenoic acid 
(15HPETE) is an arachidonate-derived lipid 
hydroperoxide which is formed by the action of 
lipoxygenase, an enzyme found in human platelets, 
leukocytes and other tissues [l-3]. Such peroxides 
have been suggested to be important in inflam- 
matory processes [4] and are potent inhibitors of 
enzymes [5,6]. Thus, 15-HPETE and other arachi- 
donate-derived lipid hydroperoxides are potential 
intermediates in pathological processes. This is of 
particular interest in the pathogenesis of cardio- 
vascular disease since leukocyte infiltration of the 
myocardium can be profound in myocarditis [7] 
and platelet aggregation is common following 
stress [8] and myocardial infarction [9]. 
Myoglobin (Mb) is an Oz-binding hemoprotein 
found in very high concentrations in mammalian 
heart and thought to function as a short-term 02 
reserve [lo] and possibly in facilitation of in- 
tracellular 02 diffusion [11,12]. Loss of Mb has 
been shown to limit the functional capacity of the 
heart [ 131. Because of the spectral characteristics 
* To whom correspondence should be addressed 
of Mb, its concentration in isolated heart cells and 
perfused heart can be directly measured [12,14]. 
Myoglobin is readily oxidized by a variety of 
agents, including peroxides [ 12,14,15]. The pur- 
pose of this study was to determine whether the 
naturally occurring lipid hydroperoxide, 15- 
HPETE, oxidizes Mb in intact heart cells. The 
results demonstrate that this oxidation occurs and 
further suggest that this type of oxidation may 
reflect on early functional change of oxidative in- 
jury to myocytes. 
2. MATERIALS AND METHODS 
[5,6,8,9,11,12,14,15-3H(N)]Arachidonic acid, 
spec. act. 60-100 Ci/mol, was obtained from New 
England Nuclear (Boston) and used to localize the 
product of the lipoxygenase reaction during isola- 
tion. Arachidonic acid, soybean lipoxygenase (type 
V), enzymes and other chemicals for cell prepara- 
tion were purchased from Sigma (St. Louis). Silicic 
acid (325 mesh, chromatographic grade) was ob- 
tained from Fisher Scientific (Fair Lawn) and 
prepared as in [ 161. Other chemicals were reagent 
grade and were purchased locally. Deionized water 
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was used throughout. 15HPETE was biosyn- 
thesized from arachidonic acid and isolated by 
silicic acid chromatography [ 171 and quantitated 
by assay with thiobarbituric acid [ 181. 
Cardiac myocytes were isolated from male rats 
(Kng:(SD)Br, King Animal Laboratories, 250-350 
g, fed ad libitum) as in [12]. Cells were quantitated 
and viability determined in the presence of 0.2% 
trypan blue [12]. Spectral changes of Mb were 
typically measured by dual-wavelength scanning 
spectrophotometry (Aminco DW2a, Travenol 
Laboratories, Chicago), in the 570-650 nm range 
with 630 nm as a reference wavelength. 
3. RESULTS AND DISCUSSION 
Addition of 15 PM 15-HPETE resulted in the 
loss of the 585 nm absorbance maximum of Mb02 
(fig. 1) in less than 5 min. This loss was not due to 
deoxygenation since the a-band of cytochrome a 
(605 nm) was not present under these conditions, 
and addition of 02-saturated buffer did not cause 
recovery of the 585 nm band. Spectra of deox- 
ygenated and KCN-treated cells are available for 
comparison [ 191. Because other peroxides oxidize 
Mb (or MbO2) to either metMb or ferrylMb, we 
felt that it was likely that the Mb02 was being con- 
verted to one of these forms. FerrylMb has 
previously been identified in ethyl hydrogen 
peroxide-perfused rat heart by addition of Na2S to 
produce sulfMb [14,20]. The sulfide adds to the 
periphery of the porphyrin ring to produce a 
chlorin structure which has a characteristic intense 
absorption maximum at 616 nm for the deoxy fer- 
rous form. The maximum shifts to 624 nm in the 
oxygenated form which is formed at several at- 
mospheres 02 [21, 221. Metsulfmyoglobin has an 
absorption maximum at 595 nm, but has a much 
lower extinction value [22]. 
Addition of 1 mM Na$ to 15-HPETE-treated 
heart cells produced an absorption maximum at 
617 nm as expected for the formation of ferrous 
sulfMb (fig. 1). This spectrum was the same as that 
obtained by addition of Na2S to ethyl hydrogen 
peroxide-treated cells (not shown) and is therefore 
indicative of the presence of ferrylMb in the 
15-HPETE-treated cells. Addition of NazS to un- 
treated oxygenated or deoxygenated cells did not 
result in the formation of the 617 nm maximum. 
Furthermore, addition of Na2S to cells in which 
AA = 0.02 
Fig. 1. Oxidation of Mb in isolated cardiac myocytes by 
15-HPETE. Spectra were obtained in the dual- 
wavelength scanning mode of an Aminco DW2a spec- 
trophotometer with 630 nm as the reference wavelength. 
A spectrum in the 570-650 nm range shows Mb02 
(- ) with a maximum absorbance at 585 nm. Addi- 
tion of IS-HPETE (-. -) produced essentially complete 
loss of Mb02 within 5 min. The product of this reaction 
was predominantly ferrylMb, identified by its conver- 
sion to ferrous sulfMb which occurred when 1 mM Na2S 
(---) was added. Maximum absorbance of ferrous 
sulfMb occurs at about 617 nm. The light path was 1 cm, 
sample temperature 37”C, and cell concentration 4 x 
10’ cells/ml in a Hepes-supplemented modified Krebs- 
Henseleit buffer (pH 7.4). Data are from one experiment 
which is representative of studies on 5 cell preparations. 
The baseline obtained with water under these conditions 
was characteristically skewed. However, because the tur- 
bidity of the cells contributes to the measured AA, direct 
subtraction of this baseline is not valid for correction of 
the spectra. 
Mb was converted to metB by minimal treatment 
with Hz02 [12] did not result in formation of this 
maximum, but rather caused a minor increase in 
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absorbance in the 600 nm region. Addition of 1 
mM KCN to HzOz-treated, anaerobic cells resulted 
in an increased absorbance in the region of 545 
nm, consistent with the formation of cyano- 
metMb. The same addition to 15HPETE-treated 
cells had very little effect on the spectrum in this 
region and was consistent with the identification of 
the product of the reaction with 15HPETE as fer- 
rylMb. Using the change in extinction coefficient 
on forming ferrous sulfMb (AC = 10.5 mM - ’ - 
cm-’ for the wavelength pair 617 minus 600 nm 
calculated from [21]), the amount of ferrous 
sulfMb formed was 4.9-6.8 nmol/106 cells. Since 
these cells contain about 8 nmol Mb/lo6 cells as 
isolated, most of the Mb appears to be oxidized by 
I5-HPETE to the ‘ferryl’ form. 
The initial rate of Mb oxidation by 15-HPETE 
was linear within the sensitivity of the assay (fig. 
2). Free-radical-initiated lipid peroxidation in liver 
cells typically has a lag phase of several minutes 
[23]. The absence of a lag phase indicates that Mb 
is directly oxidized by 15-HPETE. Moreover, the 
nearly quantitative conversion of Mb to ferrylMb 
further suggests a direct oxidation since paraquat- 
initiated injury gives a mixture of oxidation pro- 
ducts of Mb in heart cells (unpublished). 
Studies of the concentration dependence of Mb 
oxidation by 15-HPETE showed that an apparent 
‘threshold’ concentration was required for Mb ox- 
idation (fig. 3). This threshold was typically 2-4 
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Fig. 2. Time course of Mb oxidation with 15HPETE. 
Cells were incubated as described in fig. 1 with 4 pM 
15HPETE and Mb content measured from the 
d&85-630. Data are from one experiment which is 
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Fig. 3. Concentration dependence of IS-HPETE- 
dependent oxidation of Mb in isolated cardiac myocytes. 
Initial rates of loss of Mb02 were measured with varying 
concentrations of 15HPETE. Cells were incubated as 
described in fig. 1 and Mb loss measured as the 
dAsss_srs. Data are from one experiment which is 
representative of 4 cell preparations. 
PM 15-HPETE and indicated that either 15- 
HPETE was not accessible to Mb at lower concen- 
trations or ferrylMb was reduced back to func- 
tional Mb at a rate comparable to the rate of ox- 
idation. Reduction of lipid hydroperoxides by 
glutathione peroxidase has been studied extensive- 
ly. Since a high glutathione peroxidase activity oc- 
curs in heart [24], the reduction of I5-HPETE by 
this enzyme may be largely responsible for the 
measured concentration dependence. Further 
studies on the activity of the glutathione perox- 
idase system as well as on the reactivity of isolated 
myoglobin (or oxymyoglobin) and 15-HPETE will 
be necessary to explain this threshold effect. 
Because the heart is known to be sensitive to in- 
jury by peroxides [14,25], we examined the effect 
of 15-HPETE on functional morphology and cell 
viability. Loss of the typical rod shape and of abili- 
ty to exclude trypan blue were both time- and 
concetration-dependent with 15-HPETE (not 
shown). The oxidation of Mb preceded these 
changes, and loss of rod shape preceded loss of the 
ability to exclude trypan blue (fig. 4). Thus, the 
temporal sequence of changes, Mb oxidation, loss 
of functional morphology and finally loss of mem- 
branal integrity, indicates that Mb oxidation may 
be an early indicator of oxidative (peroxidative) in- 
jury in heart cells. 
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Fig. 4. Comparison of sensitivity of Mb oxidation by 
IS-HPETE with change in morphology and loss in 
viability of cardiac myocytes. Loss of Mb02 (0) as 
shown by this plot of remaining Mb preceded loss in 
viability (0) of myocytes. Cells lost the normal rod 
shape (A) before cell death occurred which suggests 
damage to structural elements before membranal 
damage. Cell concentration was 4 x 10’ cells/ml, in- 
cubated for 15 min at 37’C in a Hepes-supplemented 
modified Krebs-Henseleit buffer (pH 7.4). Data are 
from two experiments matched for initial viability and 
are representative of experiments from 7 cell 
preparations. 
Many previous studies of peroxidative injury 
have focussed on the derangement of membrane 
lipids which occurs as a result of a free-radical pro- 
cess [26]. Howeve, major changes in membrane 
permeability do not occur until substantial destruc- 
tion of membrane lipids occurs and, therefore, the 
site of lethal injury may be specific proteins with 
critical functional groups which are particularly 
sensitive to peroxides or other reactive species 
generated during peroxidative processes [27]. In 
liver microsomes, we found that Ca’ + sequestra- 
tion is very sensitive to oxidative injury and that 
this appears to be due to the susceptibility of the 
Ca2 + ATPase [28]. Contractile systems in heart 
are sensitive to thiol reagents [29] and, therefore, 
are likely to be sensitive to oxidation. Mb oxida- 
tion may be a useful in situ indicator of such a 
process. 
The accessibility of exogenous peroxy fatty acids 
to the cytosolic fraction indicates that critical ox- 
idative lesions are not limited to membranal 
systems and can occur in subcellular compartments 
distinct from the site of peroxide generation. This 
is of particular interest with regard to the peroxide 
intermediates in the synthesis of prostaglandin and 
prostaglandin-like molecules. Although tissue con- 
centrations of these compounds are typically very 
low, pathologic alterations in their production 
could result in regions of relatively high concentra- 
tions . Production of peroxy fatty acids by 
neutrophils or platelets could thereby damage ad- 
jacent cells. 
Because of the presence of systems to prevent 
study injury (e.g. glutathione peroxidase [24]) and 
peroxide inhibition of cyclooxygenase [30] addi- 
tional studies are required to determine the quan- 
titative role of peroxy fatty acids in pathologic pro- 
cesses. The current studies establish that ex- 
ogenous peroxy fatty acids are accessible to the 
cytosolic region of myocytes and indicate that ox- 
idation of Mb may be an early functional change 
during oxidative stress. 
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